# Islet Allotransplantation in Type 1 Diabetes

> **NCT01705899** · PHASE1 · SUSPENDED · sponsor: **Ohio State University** · enrollment: 20 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Human Pancreatic Islets

## Key facts

- **NCT ID:** NCT01705899
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2006-11
- **Primary completion:** 2033-10
- **Final completion:** 2033-10
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Pausing of allotransplant program due to logistic issues.
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01705899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01705899, "Islet Allotransplantation in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01705899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*